Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara Sells 2,513 Shares

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 2,513 shares of the stock in a transaction on Monday, November 18th. The shares were sold at an average price of $90.81, for a total value of $228,205.53. Following the transaction, the general counsel now directly owns 248,745 shares of the company’s stock, valued at approximately $22,588,533.45. The trade was a 1.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Philip Mazzara also recently made the following trade(s):

• On Thursday, November 7th, Philip Mazzara sold 42,000 shares of Astera Labs stock. The stock was sold at an average price of $96.56, for a total value of $4,055,520.00.
• On Wednesday, October 9th, Philip Mazzara sold 25,000 shares of Astera Labs stock. The stock was sold at an average price of $60.74, for a total value of $1,518,500.00.
• On Monday, August 26th, Philip Mazzara sold 8,000 shares of Astera Labs stock. The shares were sold at an average price of $43.12, for a total transaction of $344,960.00.
• On Friday, August 23rd, Philip Mazzara sold 42,090 shares of Astera Labs stock. The stock was sold at an average price of $40.43, for a total value of $1,701,698.70.

Astera Labs Price Performance

Shares of ALAB opened at $97.42 on Thursday. The company’s 50-day moving average is $67.17 and its 200-day moving average is $59.49. Astera Labs, Inc. has a fifty-two week low of $36.22 and a fifty-two week high of $100.09.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.06. The business had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The business’s quarterly revenue was up 47.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Astera Labs, Inc. will post -0.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Needham & Company LLC restated a “buy” rating and set a $65.00 price target on shares of Astera Labs in a report on Wednesday, October 9th. Morgan Stanley raised their price objective on shares of Astera Labs from $74.00 to $94.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Citigroup assumed coverage on shares of Astera Labs in a research note on Monday. They set a “buy” rating and a $120.00 target price for the company. Roth Mkm raised their price target on shares of Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Finally, Barclays increased their price target on shares of Astera Labs from $70.00 to $87.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $94.67.

Institutional Trading of Astera Labs

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ALAB. Strategic Blueprint LLC increased its holdings in shares of Astera Labs by 3.6% during the third quarter. Strategic Blueprint LLC now owns 5,684 shares of the company’s stock valued at $298,000 after acquiring an additional 195 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Astera Labs by 5.7% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company’s stock valued at $277,000 after purchasing an additional 284 shares during the last quarter. Hollencrest Capital Management bought a new position in shares of Astera Labs during the 3rd quarter valued at approximately $26,000. Venturi Wealth Management LLC boosted its holdings in shares of Astera Labs by 26.3% in the third quarter. Venturi Wealth Management LLC now owns 2,400 shares of the company’s stock worth $126,000 after acquiring an additional 500 shares during the period. Finally, US Bancorp DE purchased a new stake in shares of Astera Labs in the third quarter worth about $46,000.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.